Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Mouse Presenilin-1 Knockouts Have Lowered Levels of Aβ Peptides
24 September 2001. Mutations in the presenilin 1 gene (PS1) are responsible for most cases of early-onset familial Alzheimer's disease (FAD). These mutations are accompanied by an increase in β-amyloid peptides, in particular Aβ42. In cell culture, PS1 deletion results in a reduction of Aβ peptides, suggesting that inhibiting PS1 may be one possible therapeutic approach to controlling this disease. Such deletions have not been examined in vivo, however, as PS1 knockouts die in utero. In the September 13 Neuron, Jie Shen from the Center for Neurologic Diseases at Brigham and Women's Hospital, Massachusetts, and colleagues, have successfully raised PS1 conditional knockout mice to adulthood.

Morphologically, the hippocampus and neocortex of the cKO mice appeared normal. The mice exhibited a marked reduction in cortical PS1 expression beginning at age six weeks. Levels of amyloid precursor protein (APP) remained normal, even in six-month-old mice; however, levels of C-terminal fragments of APP had accumulated to 30-fold higher than normal by that age. In contrast, levels of the peptides Aβ40 and Aβ42, which are products of g-secretase, were significantly reduced in three- to six-month-old animals, confirming previous in-vitro work as well as the suggestion that PS1 and g-secretase are closely associated.

The mice appeared generally healthy. For example, though PS1 is required for embryonic Notch signaling, Notch's downstream targets were expressed normally. Likewise, synaptic transmission and plasticity were unaffected, though the animals did show a slight loss of long-term memory. The main value of the paper is showing that PS1-dependent g-cleavage is active in adults, but it is hard to make firm conclusions about the effect on Notch signaling as only a limited number of Notch targets were examined, comments Edward Koo from the University of California San Diego.-Tom Fagan.

Reference:Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi T, Younkin L, Fedeles B, Wilson MA, Younkin S, Kandel ER, Kirkwood A, Shen J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron. 2001 Sep 13;31(5):713-26. Abstract

 
Comments on News and Primary Papers
  Primary Papers: APP processing and synaptic plasticity in presenilin-1 conditional knockout mice.

Comment by:  Miguel Rodríguez-Manotas
Submitted 22 March 2011  |  Permalink Posted 22 March 2011
  I recommend this paper

Keeping in mind everything that is currently known about PS1 and its main substrate, APP, this paper by Yu et al. was a pioneer in studying the consequences of PS1 inactivation on cognitive deficit. Despite not being recent, there are still some ideas that can be drawn from reading it.

In the cortex of the PS1 cKO mouse, two carboxy-terminal fragments, C89 and C83, were clearly increased as a result of increased availability of substrate, APP, for the cleavage reactions of α- and β-secretase, respectively. Both were elevated by as much as 30-fold (Figure 4 of the paper), whereas C99, another β-secretase cleavage product, was only increased threefold.

Apart from the increased availability of APP for β cleavage, less than half of the total amount of Aβ (Aβ40 and Aβ42) forms in the cortex of PS1 cKO mouse cortex compared to control (Table 2 of paper), because less than half of the amount of C99 is cleaved by γ-secretase. In other words, something has happened with γ cleavage, because PS1 was conditionally knocked out. But in addition, the relatively small increase in C99 is...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad